2023 annual financial data
Aktis Oncology 2023 Operating margin
Direct answer
Operating margin was -128.29%.
Operating income was -34,794,000 USD and net income was -28,641,000 USD.
Operating cash flow was -30,004,000 USD.
Get free Aktis Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 27,121,000 USD
- Operating income
- -34,794,000 USD
- Net income
- -28,641,000 USD
- Operating cash flow
- -30,004,000 USD